Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer

J. D. Hurt, D. L. Richardson, L. G. Seamon, J. F. Fowler, L. J. Copeland, D. E. Cohn, E. Eisenhauer, R. Salani, D. M. O'Malley

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences